Headline
The latest stories from AHA Today.
The AHA Aug. 28 urged the Drug Enforcement Administration to reconsider its proposed 2019 aggregate production quotas for certain controlled substances, which the agency said would reduce manufacturing quotas for six frequently misused opioids by an average 10 percent.
Legislators sent a letter to the Health Resources and Services Administration urging the agency to implement regulations to better administer the 340B drug savings program.
The Centers for Medicare & Medicaid Services Aug. 27 released an evaluation report for the first performance year of the agency鈥檚 Next Generation Accountable Care Organization Model.
The Senate last night voted 85-7 to pass an $857 billion spending package, which includes bills that would fund the departments of Health and Human Services, Defense and Labor for fiscal year 2019.
The Department of Health and Human Services鈥 Office of Inspector General seeks comments on how it can modify the anti-kickback statute and exceptions to the beneficiary inducements civil monetary penalty definition of 鈥渞emuneration.鈥
The Centers for Medicare & Medicaid Services yesterday announced a new payment and service delivery model as part of a multi-pronged strategy to combat the nation鈥檚 opioid crisis.
The Food and Drug Administration recently authorized the temporary import of hydromorphone hydrochloride injection from Canada to address a critical shortage of the drug, an opioid pain medication.
Health care and public health professionals can register to attend a Sept. 19-20 workshop in Omaha, Neb., on preparing for emerging infectious diseases, such as Ebola.
In children, antibiotics are the leading cause of emergency department visits for adverse drug events.
The AHA today expressed support for and urged all senators to support an amendment to the Labor, Health and Human Services and Education appropriations bill that would help address the out-of-control cost of prescription drugs.